Clinical Trial Update: Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)

View source ↗

Summary

Clinical trial NCT06586892 evaluating dynamic contrast-enhanced MRI as a biomarker for orodental injury after radiotherapy; the study sponsored by MD Anderson C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orodental Injury

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Orodental Injury | Status: RECRUITING